148 related articles for article (PubMed ID: 22178270)
1. Transcriptional regulation of miR-224 upregulated in human HCCs by NFκB inflammatory pathways.
Scisciani C; Vossio S; Guerrieri F; Schinzari V; De Iaco R; D'Onorio de Meo P; Cervello M; Montalto G; Pollicino T; Raimondo G; Levrero M; Pediconi N
J Hepatol; 2012 Apr; 56(4):855-61. PubMed ID: 22178270
[TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in hepatocellular carcinoma.
Xie Q; Chen X; Lu F; Zhang T; Hao M; Wang Y; Zhao J; McCrae MA; Zhuang H
Cancer; 2012 May; 118(9):2431-42. PubMed ID: 21989846
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
Xia H; Ooi LL; Hui KM
Hepatology; 2013 Aug; 58(2):629-41. PubMed ID: 23471579
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide screening reveals that miR-195 targets the TNF-α/NF-κB pathway by down-regulating IκB kinase alpha and TAB3 in hepatocellular carcinoma.
Ding J; Huang S; Wang Y; Tian Q; Zha R; Shi H; Wang Q; Ge C; Chen T; Zhao Y; Liang L; Li J; He X
Hepatology; 2013 Aug; 58(2):654-66. PubMed ID: 23487264
[TBL] [Abstract][Full Text] [Related]
5. MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling.
Wong QW; Ching AK; Chan AW; Choy KW; To KF; Lai PB; Wong N
Clin Cancer Res; 2010 Feb; 16(3):867-75. PubMed ID: 20103675
[TBL] [Abstract][Full Text] [Related]
6. Tumour necrosis factor alpha decreases glucose-6-phosphatase gene expression by activation of nuclear factor kappaB.
Grempler R; Kienitz A; Werner T; Meyer M; Barthel A; Ailett F; Sutherland C; Walther R; Schmoll D
Biochem J; 2004 Sep; 382(Pt 2):471-9. PubMed ID: 15167811
[TBL] [Abstract][Full Text] [Related]
7. Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1α in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients.
Wang C; Song B; Song W; Liu J; Sun A; Wu D; Yu H; Lian J; Chen L; Han J
J Gastroenterol Hepatol; 2011 Nov; 26(11):1630-7. PubMed ID: 21557766
[TBL] [Abstract][Full Text] [Related]
8. miR-21 promotes migration and invasion by the miR-21-PDCD4-AP-1 feedback loop in human hepatocellular carcinoma.
Zhu Q; Wang Z; Hu Y; Li J; Li X; Zhou L; Huang Y
Oncol Rep; 2012 May; 27(5):1660-8. PubMed ID: 22322403
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/β-catenin pathway.
Xu J; Zhu X; Wu L; Yang R; Yang Z; Wang Q; Wu F
Liver Int; 2012 May; 32(5):752-60. PubMed ID: 22276989
[TBL] [Abstract][Full Text] [Related]
10. Perturbation of MicroRNA-370/Lin-28 homolog A/nuclear factor kappa B regulatory circuit contributes to the development of hepatocellular carcinoma.
Xu WP; Yi M; Li QQ; Zhou WP; Cong WM; Yang Y; Ning BF; Yin C; Huang ZW; Wang J; Qian H; Jiang CF; Chen YX; Xia CY; Wang HY; Zhang X; Xie WF
Hepatology; 2013 Dec; 58(6):1977-91. PubMed ID: 23728999
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-155 is involved in the remodelling of human-trophoblast-derived HTR-8/SVneo cells induced by lipopolysaccharides.
Dai Y; Diao Z; Sun H; Li R; Qiu Z; Hu Y
Hum Reprod; 2011 Jul; 26(7):1882-91. PubMed ID: 21515911
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells.
Liu WH; Yeh SH; Lu CC; Yu SL; Chen HY; Lin CY; Chen DS; Chen PJ
Gastroenterology; 2009 Feb; 136(2):683-93. PubMed ID: 19027010
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
[TBL] [Abstract][Full Text] [Related]
14. Hepatic expression of the tumor necrosis factor family member lymphotoxin-beta is regulated by interleukin (IL)-6 and IL-1beta: transcriptional control mechanisms in oval cells and hepatoma cell lines.
Subrata LS; Lowes KN; Olynyk JK; Yeoh GC; Quail EA; Abraham LJ
Liver Int; 2005 Jun; 25(3):633-46. PubMed ID: 15910501
[TBL] [Abstract][Full Text] [Related]
15. MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma.
Fornari F; Gramantieri L; Ferracin M; Veronese A; Sabbioni S; Calin GA; Grazi GL; Giovannini C; Croce CM; Bolondi L; Negrini M
Oncogene; 2008 Sep; 27(43):5651-61. PubMed ID: 18521080
[TBL] [Abstract][Full Text] [Related]
16. Primate-specific microRNA-637 inhibits tumorigenesis in hepatocellular carcinoma by disrupting signal transducer and activator of transcription 3 signaling.
Zhang JF; He ML; Fu WM; Wang H; Chen LZ; Zhu X; Chen Y; Xie D; Lai P; Chen G; Lu G; Lin MC; Kung HF
Hepatology; 2011 Dec; 54(6):2137-48. PubMed ID: 21809363
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells.
Salvi A; Sabelli C; Moncini S; Venturin M; Arici B; Riva P; Portolani N; Giulini SM; De Petro G; Barlati S
FEBS J; 2009 Jun; 276(11):2966-82. PubMed ID: 19490101
[TBL] [Abstract][Full Text] [Related]
18. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells.
Fornari F; Gramantieri L; Giovannini C; Veronese A; Ferracin M; Sabbioni S; Calin GA; Grazi GL; Croce CM; Tavolari S; Chieco P; Negrini M; Bolondi L
Cancer Res; 2009 Jul; 69(14):5761-7. PubMed ID: 19584283
[TBL] [Abstract][Full Text] [Related]
19. [Expression of Raf kinase inhibitor protein and its significance in invasion and metastasis of hepatocellular carcinoma].
Wu XH; Wang SX; Yang YJ; Li JK; Xu Z; Tang RF
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):358-62. PubMed ID: 21875465
[TBL] [Abstract][Full Text] [Related]
20. miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells.
Li N; Fu H; Tie Y; Hu Z; Kong W; Wu Y; Zheng X
Cancer Lett; 2009 Mar; 275(1):44-53. PubMed ID: 19006648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
